XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

Search

Helmerich & Payne Inc

Open

SectorEnergy

37.3 0.35

Overview

Share price change

24h

Current

Min

36.81

Max

37.75

Key metrics

By Trading Economics

Income

-26M

-84M

Sales

5.3M

1B

P/E

Sector Avg

7.106

66.822

Dividend yield

2.81

Profit margin

-8.233

Employees

15,700

EBITDA

-31M

124M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+2.17% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.81%

3.56%

Next Earnings

6 maj 2026

Next Dividend date

29 maj 2026

Next Ex Dividend date

14 maj 2026

Market Stats

By TradingEconomics

Market Cap

117M

3.5B

Previous open

36.95

Previous close

37.3

News Sentiment

By Acuity

47%

53%

53 / 137 Ranking in Energy

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Helmerich & Payne Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Helmerich & Payne Inc Forecast

Price Target

By TipRanks

2.17% upside

12 Months Forecast

Average 37.27 USD  2.17%

High 43 USD

Low 30 USD

Based on 11 Wall Street analysts offering 12 month price targets forHelmerich & Payne Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

6

Buy

4

Hold

1

Sell

Technical Score

By Trading Central

N/A / 19.55Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

53 / 137 Ranking in Energy

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Helmerich & Payne Inc

Helmerich & Payne, Inc., together with its subsidiaries, provides drilling solutions and technologies for oil and gas exploration and production companies. The company operates through North America Solutions, Offshore Gulf of Mexico, and International Solutions segments. The North America Solutions segment conducts operations primarily in Texas, as well as in Colorado, Louisiana, New Mexico, North Dakota, Ohio, Oklahoma, Pennsylvania, Utah, West Virginia, and Wyoming. The Offshore Gulf of Mexico segment has drilling operations in Louisiana and in U.S. federal waters in the Gulf of Mexico. The International Solutions segment conducts drilling operations in Saudi Arabia, Argentina, Bahrain, Australia, Colombia, and the United Arab Emirates. The company focuses on developing, promoting, and commercializing technologies designed to enhance the drilling operations, as well as wellbore quality and placement. It also owns and operates commercial real estate properties. In addition, the company's real estate investments include a shopping center. Helmerich & Payne, Inc. was founded in 1920 and is headquartered in Tulsa, Oklahoma.
help-icon Live chat